Abiopharma

New Form 424B2 - BARCLAYS BANK PLC <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001918704-26-023647 <b>Size:</b> 566 KB

Financial Statements and Related Announcement: Half Yearly Results

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001918704-26-023646 <b>Size:</b> 1 MB

New Form SCHEDULE 13G/A - ARTELO BIOSCIENCES, INC. <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001213900-26-088826 <b>Size:</b> 10 KB

New Form SCHEDULE 13G - Kandal M Venture Ltd <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001947975-26-000018 <b>Size:</b> 23 KB

enCore Energy Reports Q2 2026 Financial Results

New Form 424B2 - BANK OF AMERICA CORP /DE/ <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001918704-26-023645 <b>Size:</b> 1 MB

New Form SCHEDULE 13G/A - DoubleVerify Holdings, Inc. <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001167557-26-000184 <b>Size:</b> 8 KB

Cellectar Biosciences Reports Second Quarter 2026 Financial Results and Provides Corporate Updates

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001918704-26-023642 <b>Size:</b> 780 KB

New Form SCHEDULE 13G/A - AETHLON MEDICAL INC <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001213900-26-088823 <b>Size:</b> 10 KB

New Form FWP - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001918704-26-023643 <b>Size:</b> 1 MB

Liminatus Pharma Announces Transfer to Nasdaq Capital Market and Extension to Regain Compliance with Minimum Bid Price Requirement

SES AI Appoints Paul Diemer to Board of Directors

Mobix Labs Signs Definitive Rare Earth Elements Deal, Expanding National Security Platform; Hosts Investor Call Today at 4:15pm ET